• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events > Best Science for the most neglected: Where do we stand 10 years on? > Page 2

Best Science for the most neglected: Where do we stand 10 years on?

4-5 December 2013

Institut Pasteur, Paris, France

  • Programme and Presentation
    • Overview
    • Programme and Presentations
    • Photos
    • Awards Ceremony
    • Press Release
    • Press Clippings
    • Symposium
    • Symposium Photos
    • Model Report
    • Collection

Programme and Presentations

5 DECEMBER CONFERENCE PROGRAMME 

Session Notes

Opening Session


M
oderator: Dr Pierre-Etienne Bost,Chair of DNDi Scientific Advisory Committee, formerly Institut Pasteur, France [Video]

Opening Addresses:

  • Prof. Christian Bréchot, President, Institut Pasteur, France [Video]
  • Prof. Marcel Tanner, Director, Swiss Tropical and Public Health Institute (Swiss TPH), Chair of DNDi Board of Directors, Switzerland [Video]
  • Dr Claire Rieux, Vice President, Médecins Sans Frontières, France [Video]
  • Dr Rhona MacDonald, Senior Editor, PLOS Medicine, UK [Video]


Keynote Presentation: Reflecting on ten years of progress in the fight against AIDS, TB and malaria

  • Prof Michel Kazatchkine, UN Secretary General Special Envoy on HIV/AIDS in Eastern Europe and Central Asia & Senior Fellow, Global Health Program, the Graduate Institute of International and Development Studies, Geneva, Switzerland [Video]

10 Years of Portfolio Building for Neglected Diseases: a PDP Experience

Chair: Dr Tim Wells, Chief Scientific Officer, Medicines for Malaria Venture (MMV), Switzerland [Video]  Overview Presentation: The Origins of DNDi

  • Yves Champey, Consultant and former Chair of DNDi Board of Directors, France [Video]

Perspectives Presentation:

10 Years of Portfolio Building for Neglected Diseases: A DNDi Experience

  • Prof. Simon Croft, Dean, Faculty of Infectious and Tropical Diseases, London School of Tropical Medicine and Hygiene, formerly Director of Research and Development, DNDi, UK [Video]
  • Dr Shing Chang, Consultant, and former Director of Research and Development, DNDi, USA [Video]
  • Dr Graeme Bilbe, Director of Research and Development, DNDi, Switzerland [Video]

 

Main Progress and Key Challenges in Drug Discovery for Infectious Diseases in the Past Decade

Chair: Prof. Alan Fairlamb, Professor of Biochemistry and Wellcome Principal Research Fellow, College of Life Sciences, University of Dundee, UK [Video]

Keynote Presentation:

Progress and Challenges in Infectious Diseases Drug Discovery 

  • Prof. Dyann Wirth, Richard Pearson Strong Professor of Infectious Diseases, Harvard University and The Broad Institute [Video]

Panel Discussion:

  • Dr James McKerrow, Director, Center for Discovery and Innovation in Parasitic Diseases, University of California, San Francisco USA [Video]
  • Prof. Philippe Sansonetti, Director, Molecular Microbial Pathogenesis, Institut Pasteur, France [Video]
  • Dr Gerald Spaeth, Head of Laboratory, Molecular Parasitology and Signaling Unit, Institut Pasteur, France [Video]
  • Dr Nick Cammack, Senior Vice President and Head of the Tres Cantos Medicines Development Campus at GSK, Spain [Video]
  • Q & A [Video]
Breakthroughs and Challenges in Clinical Development

Chair: Prof. Nick White, Professor of Tropical Medicine, Mahidol University, Thailand [Video]

Keynote Speech: Dr Elias Zerhouni, President, Global R&D, Sanofi, France [Video]

Panel Discussion:

  • Dr Lance Gordon, Director for Neglected Infectious Diseases in the Global Health Program, Bill & Melinda Gates Foundation, USA [Video]
  • Prof. Ogobora Doumbo, Director, Malaria Research and Training Centre, University of Bamako, Mali [Video]
  • Dr Leonard Sacks, Associate Director for Clinical Methodology, CDER, Food and Drug Administration (FDA), USA [Video]
  • Dr Jaideep A. Gogtay, Chief Medical Director, Cipla Ltd, India [Video]
  • Q & A [Video]
The Future of Research on Neglected Diseases


Chair:
Ms Ellen ‘t Hoen, Consultant, medicines law and policy, The Netherlands [Video]
Keynote Speech:
Dr Philippe Douste-Blazy, Chair of the Executive Board, UNITAID, France [Video]

Panel Discussion:

  • Dr Charles Clift, Senior Consulting Fellow, Centre on Global Health Security, Chatham House, UK [Video]
  • Dr Line Matthiessen, Head of Infectious Diseases and Public Health Unit, DG Research and Innovation, European Commission, Belgium [Video]
  • Dr Christophe Paquet, DTO/SAN Santé et protection sociale, Agence Française du Développement (AFD), France [Video]
  • Dr Joanne Liu, International President, Médecins Sans Frontières, Switzerland [Video]
  • Dr Bernard Pécoul, Executive Director, DNDi, Switzerland [Video]
  • Q & A [Video]
Awards Ceremony

Awards Ceremony for “Project of the Year” and “Partnership of the Year [Video]

Closing Session


Closing Remarks by the Representative of the French Government: Mr Djillali Annane
, Conseiller Recherche et Eduction de la Ministre des Affaires Sociales, France

Closing Remarks:
 Prof Marcel Tanner, Chair DNDi Board of Directors, Director Swiss Tropical and Public Health Institute, Switzerland [Video]

Pages: Page 1, Page 2, Page 3, Page 4, Page 5, Page 6, Page 7, Page 8, Page 9, Page 10

Other events

Loading...
15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

15-18 June 2025

Manila, Philippines

8th Asia Dengue Summit

22 May 2025

Online event

MSF Scientific Days

21 May 2025, 9-10:30 AM

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License